Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.53 |
| ▸ | KDM5A | P29375 | 4/20 | 0.53 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.53 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.49 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27285975 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL7571174 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL394099 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL73050 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984529 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL448290 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL2802094 | 0.98 | KDM4C (0.51) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL1272817 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16895244 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL10610457 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117887707-A | Extraction kit and method for extracting RNA of common plant based on magnetic beads | 武汉纳磁生物科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117887707-A | Extraction kit and method for extracting RNA of common plant based on magnetic beads | 武汉纳磁生物科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117821447-A | Extraction kit and extraction method for extracting blood RNA by magnetic bead method | 武汉纳磁生物科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-11802107-B2 | Compounds and methods of use | SIGNUM BIOSCIENCES, INC. (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230285262-A1 | Skin Compositions and Uses | Stemetrix, Inc. (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230174467-A1 | COMPOUNDS AND METHODS OF USE | SIGNUM BIOSCIENCES, INC. (US) | 2023-06-08 | — | — | US | disclosed |
| US-11518738-B2 | Compounds and methods of use | SIGNUM BIOSCIENCES, INC. (US) | 2022-12-06 | — | — | US | disclosed |
| US-10975023-B2 | Compounds and methods of use | SIGNUM BIOSCIENCES, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| US-20200017438-A1 | COMPOUNDS AND METHODS OF USE | SIGNUM BIOSCIENCES, INC. (US) | 2020-01-16 | — | — | US | disclosed |
| US-20170216180-A1 | Skin Compositions and Uses | Stemetrix, Inc. (US) | 2017-08-03 | — | — | US | disclosed |
| EP-2968474-A1 | SKIN COMPOSITIONS AND USES | Stemetrix, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-105163706-A | Microcapsules comprising sunscreen agents | TAGRA BIOTECHNOLOGIES LTD | 2015-12-16 | — | — | CN | disclosed |
| WO-2014160496-A1 | SKIN COMPOSITIONS AND USES | Stemetrix, Inc. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140271507-A1 | Skin Compositions and Uses | Stemetrix, Inc. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802107-B2 | Compounds and methods of use | MMP8, CUTA, B3GNT2 | KDM4C 1614/4885KDM5A 1576/4885PHF8 2373/4885 |
| US-20200017438-A1 | COMPOUNDS AND METHODS OF USE | MMP8, CUTA, MPO | KDM4C 1657/4885KDM5A 1690/4885PHF8 2512/4885 |
| US-10975023-B2 | Compounds and methods of use | MMP8, CUTA, MPO | KDM4C 1657/4885KDM5A 1690/4885PHF8 2512/4885 |
| US-20230174467-A1 | COMPOUNDS AND METHODS OF USE | MMP8, CUTA, B3GNT2 | KDM4C 1614/4885KDM5A 1576/4885PHF8 2373/4885 |
| US-11518738-B2 | Compounds and methods of use | MMP8, CUTA, B3GNT2 | KDM4C 1614/4885KDM5A 1576/4885PHF8 2373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.